CompletedNot Applicable

Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

Italy, Spain1,000 participantsStarted 2012-04

Plain-language summary

The purpose of this study is to determine whether Magnetic Resonance Imaging may predict the risk of Intracerebral Hemorrhage for patients with ischemic stroke who receive indefinite oral anticoagulation

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age \> 65 y
✓. TIA or ischemic stroke
✓. The patient will receive indefinitely treatment with oral anticoagulants for the secondary prevention of cardioembolic stroke
✓. No previous treatment with oral anticoagulants
✓. Signed consent before performing a Magnetic Resonance
✓. Long-term follow-up will be possible

Exclusion criteria

✕. The patient will receive oral anticoagulation as a primary prevention treatment
✕. The etiology that motivates the onset of oral anticoagulants is not cardioembolism
✕. Absolute contraindication to receive oral anticoagulants
✕. Arterial hypertension that is not controlled, hypertensive crisis
✕. Dementia
✕. Live-expectancy less than 1 year
✕. Any social or psychological reason that prevents follow-up
✕. Contraindication to perform a Magnetic Resonance examination

What they're measuring

Intracranial Hemorrhage

Timeframe: every 3 months after stroke, until 24 months

Trial details

NCT IDNCT02238470

SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-09

View on ClinicalTrials.gov More Ischemic Stroke trials